Posts Tagged ‘association’

Older Entries

Breast Cancer and Diabetes Mellitus

9, Jun 2010

Exp Clin Endocrinol DiabetesDOI: 10.1055/s-0030-1254116AbstractBreast cancer is the leading neoplastic malignancy among females worldwide.

EDAP Received Significant Visibility for Ablatherm-HIFU at American Urological Association Annual Meeting

8, Jun 2010

LYON, France, June 8, 2010 (GLOBE NEWSWIRE) — EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that it was a major participant at the American Urological Association (AUA) 2010 Annual Meeting, held May 29 — June 3, 2010 in San Francisco. As part of the scientific program, four abstracts were presented that outlined the long-term positive European experience utilizing EDAP’s Ablatherm-HIFU treatment for localized prostate cancer as summarized below.

Estimating genome-wide IBD sharing from SNP data via an efficient hidden Markov model of LD with application to gene mapping

6, Jun 2010

Motivation: Association analysis is the method of choice for studying complex multifactorial diseases.

iTRAQ Quantitative Analysis of Multidrug Resistance Mechanisms in Human Gastric Cancer Cells

6, Jun 2010

Multidrug resistance (MDR) is a major obstacle towards a successful treatment of gastric cancer. However, the mechanisms of MDR are intricate and have not been fully understood.

Refusal of prostate surgery and alternative treatment reduces long-term survival

4, Jun 2010

Patients who refuse radical prostatectomy for low-risk prostate cancer have better long-term survival if they chose to undergo alternative rather than no treatment, show study results presented at the 2010 American Urology Association’s annual meeting in San Francisco, USA, this week. (Source: MedWire News – Prostate Cancer) MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network , and receive $5 free advertising


Older Entries

Copryright 2012 - Epione Medical Corporation | About us | Treatments | Contact us | Online Store

Share to Facebook Share to Twitter Stumble It Email This More...